Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
about
Other targeted drugs in melanomaIn Vitro Antiproliferative Activity of Extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzkaMicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene.Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.Targeting multiple key signaling pathways in melanoma using leelamine.BRAF and NRAS mutations are heterogeneous and not mutually exclusive in nodular melanomaHigh expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in MiceInsulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells.By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasisHERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.Timosaponin AIII induces apoptosis and autophagy in human melanoma A375-S2 cells.Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma.Role of the protein kinase BRAF in the pathogenesis of endometriosis.Malignant transformation of infantile hemangioma to angiosarcoma: response to chemotherapy with bevacizumab.Yes-Associated Protein (YAP) Promotes Tumorigenesis in Melanoma Cells Through Stimulation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1).Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma.Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.
P2860
Q26775594-A72E2E88-7A05-461D-9B63-8DE951D612B4Q33792750-F8596A9C-22BC-4C8A-A8DB-3E35B035A9D0Q33886196-D5DD6DC6-8C96-48D3-89CC-3F8E7DD1D021Q34413011-28580370-91F5-42CF-9F90-1EC93CF1A1A8Q35136450-3BA8ED29-BCC8-434F-90B2-6174E7219B54Q35141834-56EDC45B-67AC-4314-B2CD-31CE75FBBB4BQ35406015-5B059995-7B75-4ABC-AF4A-77CB8E9EE2E1Q36048258-AB8B29CB-3F38-480C-86C4-22CAB9B5AEA5Q36299770-760DEA79-17FF-4145-A4C6-3478249B13F6Q36413730-12450589-D6E3-41AA-B46D-414EA89E07CCQ37609891-22DF7EBE-739A-49BF-AF6C-C34DD554969DQ38766103-3F769EB4-7310-414D-9435-B895F3C1FF82Q39434922-4A66B1F8-CD18-4E72-B3B9-30360949992FQ39844384-99C731B4-5A6B-48D3-ABEA-4E78DBEBD3D7Q46061982-8A4F11D1-EE85-4B5C-94BB-EB0D095ADA95Q47133751-3859719C-7D8C-4372-944A-7263525CF426Q53747880-708B9239-6CFB-4F50-9FD4-9CBCD32B4359Q55427672-10930A13-2CF0-453C-BA32-395997712FC5
P2860
Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
@en
type
label
Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
@en
prefLabel
Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
@en
P2860
P356
P1433
P1476
Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
@en
P2093
Ao-Xue Wang
Xiao-Yi Qi
P2860
P304
P356
10.1002/IUB.1193
P577
2013-07-29T00:00:00Z